Tempus AI (TEM) to Release Quarterly Earnings on Tuesday

Tempus AI (NASDAQ:TEM) will likely be announcing its Q3 2025 results after the market closes on Tuesday, November 4th. Analysts expect the company to announce earnings of ($0.16) per share and revenue of $328.8910 million for the quarter. Tempus AI has set its FY 2025 guidance at EPS.Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Tuesday, November 4, 2025 at 4:30 PM ET.

Tempus AI (NASDAQ:TEM) last issued its earnings results on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.23) by $0.01. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. During the same period in the prior year, the firm earned ($6.86) earnings per share. Tempus AI’s revenue for the quarter was up 89.5% on a year-over-year basis. On average, analysts expect Tempus AI to post $-6 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Tempus AI Price Performance

Shares of NASDAQ:TEM opened at $89.85 on Friday. The stock’s 50 day moving average is $85.42 and its 200-day moving average is $69.66. Tempus AI has a twelve month low of $31.36 and a twelve month high of $104.32. The firm has a market capitalization of $15.61 billion, a price-to-earnings ratio of -75.50 and a beta of 4.87. The company has a quick ratio of 1.43, a current ratio of 1.54 and a debt-to-equity ratio of 2.58.

Insider Transactions at Tempus AI

In other Tempus AI news, Director Theodore Leonsis sold 44,000 shares of the company’s stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $69.90, for a total value of $3,075,600.00. Following the completion of the transaction, the director owned 86,756 shares in the company, valued at $6,064,244.40. This represents a 33.65% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Andrew Polovin sold 5,398 shares of the company’s stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $402,960.70. Following the completion of the transaction, the executive vice president owned 132,056 shares of the company’s stock, valued at $9,857,980.40. This trade represents a 3.93% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders have sold 1,099,912 shares of company stock worth $87,247,931. Company insiders own 26.27% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the company. EverSource Wealth Advisors LLC grew its stake in shares of Tempus AI by 88.8% during the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock worth $44,000 after acquiring an additional 325 shares during the period. Brown Advisory Inc. boosted its stake in Tempus AI by 22.3% in the 2nd quarter. Brown Advisory Inc. now owns 5,307 shares of the company’s stock worth $337,000 after purchasing an additional 969 shares during the period. Russell Investments Group Ltd. boosted its stake in Tempus AI by 21.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 6,527 shares of the company’s stock worth $415,000 after purchasing an additional 1,146 shares during the period. Benjamin Edwards Inc. boosted its stake in Tempus AI by 3.9% in the 2nd quarter. Benjamin Edwards Inc. now owns 44,839 shares of the company’s stock worth $2,849,000 after purchasing an additional 1,702 shares during the period. Finally, The Manufacturers Life Insurance Company boosted its stake in Tempus AI by 9.4% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 23,407 shares of the company’s stock worth $1,487,000 after purchasing an additional 2,020 shares during the period. Institutional investors own 24.22% of the company’s stock.

Analyst Ratings Changes

Several brokerages recently issued reports on TEM. Cowen downgraded Tempus AI from a “buy” rating to a “hold” rating in a report on Tuesday, October 21st. Needham & Company LLC reiterated a “buy” rating and set a $70.00 price target on shares of Tempus AI in a report on Friday, August 8th. HC Wainwright upped their price target on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a report on Friday, September 12th. BTIG Research upped their price target on Tempus AI from $85.00 to $96.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Morgan Stanley upped their price target on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a report on Tuesday, August 12th. Seven analysts have rated the stock with a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the stock. According to MarketBeat, Tempus AI currently has a consensus rating of “Hold” and a consensus target price of $79.38.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.